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A B S T R A C T   
Many oral bacteria reduce inorganic nitrate, a natural part of a vegetable-rich diet, into nitrite that acts as a 
precursor to nitric oxide, a regulator of vascular tone and neurotransmission. Aging is hallmarked by reduced 
nitric oxide production with associated detriments to cardiovascular and cognitive function. This study applied a 
systems-level bacterial co-occurrence network analysis across 10-day dietary nitrate and placebo interventions to 
test the stability of relationships between physiological and cognitive traits and clusters of co-occurring oral 
bacteria in older people. Relative abundances of Proteobacteria increased, while Bacteroidetes, Firmicutes and 
Fusobacteria decreased after nitrate supplementation. Two distinct microbiome modules of co-occurring bac-
teria, that were sensitive to nitrate supplementation, showed stable relationships with cardiovascular (Rothia- 
Streptococcus) and cognitive (Neisseria-Haemophilus) indices of health across both dietary conditions. A micro-
biome module (Prevotella-Veillonella) that has been associated with pro-inflammatory metabolism was dimin-
ished after nitrate supplementation, including a decrease in relative abundance of pathogenic Clostridium difficile. 
These nitrate-sensitive oral microbiome modules are proposed as potential pre- and probiotic targets to 
ameliorate age-induced impairments in cardiovascular and cognitive health.   
1. Introduction 
The human alimentary canal hosts a major microbial ecosystem and 
the metabolic outputs of these microbes make a significant contribution 
to host physiology. The symbiotic role of the gut microbiota as a 
modulator of physiological and cognitive health is well-established [1,2] 
and cross-sectional studies indicate that a perturbed oral microbial 
community and poor dental health are associated with impaired car-
diovascular and metabolic health [3]. However, relatively little is 
known about the mechanisms that underlie the host-oral microbiota axis 
as a potential modulator of human health. One mechanism by which the 
oral microbiota may influence human health is its contribution to the 
production of the signalling molecule nitric oxide (•NO), which 
regulates vascular tone, mitochondrial respiration and neurotransmis-
sion among many other functions [4–7]. 
Some facultative and obligate anaerobic oral bacteria reduce nitrate 
to bioactive nitrite, a key precursor to •NO [8]. Vegetable-rich diets, 
such as the Mediterranean and ‘Dietary Approaches to Stop Hyperten-
sion’ (DASH) diet, are abundant in dietary nitrate and oral bacteria play 
a key role in the pathway of •NO production from such dietary nitrate. 
This is particularly important in older age, where the capacity for 
endogenous •NO production via the canonical enzymic •NO synthase 
pathway has declined [9,10]. Low •NO availability contributes to the 
development of arterial hypertension, reduced physical and cognitive 
functional capacity, and increased morbidity [11,12]. The important 
role of oral bacterial nitrate reduction as a parallel pathway for 
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endogenous •NO production is demonstrated by studies showing that 
use of bactericidal mouthwash acutely reduces systemic •NO bioavail-
ability and elevates blood pressure [13,14], and that chronic, frequent 
use of mouthwash is associated with elevated risk for type II diabetes 
[15]. Conversely, increased consumption of dietary inorganic nitrate 
elevates •NO bioavailability and reduces blood pressure [16–18], im-
proves skeletal muscle contractility [19,20] and exercise efficiency [21, 
22], and enhances brain perfusion and cognitive function [23,24]. 
Elevation of •NO bioavailability via dietary means, therefore, potentially 
represents a powerful therapeutic to attenuate cognitive and cardio-
vascular decline associated with aging [25]. 
Inorganic nitrate is emerging as an effective intervention to alter the 
oral microbiome. As a prebiotic dietary intervention, nitrate appears to 
increase the abundances of bacteria belonging to Neisseria and Rothia 
genera [26–28] and decreases abundances of Prevotella and Veillonella 
species [27]. Correlational analyses with physiological traits, however, 
have been limited to single-taxon comparisons [27,29] or aggregate 
abundances of selected nitrate reducing bacteria [30,31]. Such ap-
proaches cannot detect the nuances of complex synergistic and antag-
onistic relationships that exist among the bacterial ecosystem. In in vivo 
oral ecosystems taxa that contain nitrate-reducing species can be 
co-exclusive (e.g. Neisseria and Actinomyces; [32]), and whether the 
metabolic activity of a given species is beneficial or detrimental to host 
physiology is determined by the surrounding microbial ecosystem. 
Therefore, to truly understand how the in vivo oral microbial ecosystem 
might modulate human health, a systems-level microbial co-occurrence 
network approach is required, in combination with an ‘interventionist’ 
model that tests the stability of microbiome-trait relationships across 
two distinct dietary conditions [33,34]. 
Here, we apply weighted gene co-occurrence network analysis 
(WGCNA) that was originally developed to explore human genome in-
teractions [35], in a novel context of the oral microbiome interactions 
with physiological and cognitive traits. The use of WGCNA has been 
successfully expanded to assess interactions between clinical traits and 
co-occurring gastric microbiome clusters [36], to compare intestinal 
microbiomes between healthy and clinical patient cohorts [37], and to 
assess bacterial interactions within an oral plaque [38]. In this study we 
systematically reduce the microbiome network data to interpret re-
lationships between co-occurring modules of oral bacteria and the 
physiological and cognitive traits that are regulated by •NO in older 
adults. Our application of the WGCNA concept in the form of ‘weighted 
microbiome co-occurrence network’ considers the oral microbiota as an 
ecosystem characterized by synergistic and antagonistic relationships 
among bacteria when exposed to a high-nitrate diet [35,39]. We 
assessed oral microbiomes by sequencing 16S rRNA genes in saliva 
samples from healthy older people (70-80 years old) who underwent 
dietary nitrate and placebo interventions, in conjunction with compre-
hensive assessments of physiological and cognitive function, as well as 
muscle and brain metabolism. 
The purpose of this study was to determine 1) which co-occurring 
modules of bacteria in the salivary microbiome of healthy older peo-
ple were sensitive to dietary nitrate intake, 2) which co-occurring oral 
microbiome modules correlated with cognitive and physiological traits 
across dietary interventions with placebo and nitrate, and, 3) which 
nitrate-sensitive modules represent key biomarkers, and thus probiotic 
targets, for enhancing cardiovascular and cognitive health. We estab-
lished eight distinct modules of co-occurring bacteria and revealed 
profound alterations in relative abundances of specific members of these 
clusters following dietary nitrate supplementation. We identified several 
significant correlations between oral bacteria modules and indices of 
cognitive and physiological function, which represent promising ave-
nues for translational research into biomarkers and therapies for 
cognitive and cardiovascular impairment in older age. 
2. Results 
2.1. Comparison of oral microbiomes between dietary nitrate and placebo 
conditions 
We surveyed the oral bacterial communities in saliva samples of 30 
older people following 10 days of dietary inorganic nitrate (nitrate-rich 
beetroot juice, ~750 mg NO3− /d) and placebo (nitrate-depleted beetroot 
juice, ~1 mg NO3− /d) supplementation in a randomised, placebo- 
controlled cross-over design (Fig. 1). Baseline participant characteris-
tics are shown in Table 1. Addenbrooke’s Cognitive Examination (ACE- 
III), that has been validated for the detection of cognitive impairment 
[40], was used to assess participants’ cognitive status at baseline. 
ACE-III revealed that nine participants had a score of less than 90/100 
(range 82–89) indicative of mild cognitive decline. Two participants had 
a mean arterial pressure (MAP) of >105 mmHg indicative of hyper-
tension. Amplicons of the hypervariable V1–V3 regions of bacterial 16S 
rRNA gene were amplified and sequenced by synthesis [41], and relative 
abundances of species-level taxonomic units were assigned using a 97% 
gene similarity cut-off for pairwise-identity comparisons. Rare opera-
tional taxonomic units (OTUs) of less than 10 counts of each OTU in each 
sample for both placebo and nitrate condition were removed, as well as 
OTUs which had <5 counts per person in 50% of samples. Thus, in total 
four samples were excluded, such that the final data set included 
microbiome data for placebo and nitrate conditions for 26 subjects 
(Fig. 1). 
The species richness (number of OTUs/sample), the Shannon Di-
versity and the Chao-1 index did not differ between placebo and nitrate 
conditions (Fig. 2 AB). The salivary microbiome compositions were 
compared between conditions using non-metric multidimensional 
scaling (NMDS) ordination based on Bray-Curtis dissimilarity, coupled 
with t-tests and Benjamini-Hochberg false discovery rate correction 
[42]. This analysis revealed a shift in microbial community between 
conditions, as indicated by distinct clustering of placebo and nitrate 
samples (Fig. 2 C). Significant phylum-level shifts in relative abundance 
following nitrate supplementation included a marked increase in Pro-
teobacteria, which occurred in concert with decreases in Firmicutes, 
Bacteroidetes and Fusobacteria. Overall, relative abundances of 23 
genera and 24 species were different between placebo and nitrate con-
ditions following α-adjustment for multiple comparisons (Table S1). 
Nitrate supplementation increased the abundances of 10 species, while 
decreasing the abundances of 14 others. 
2.2. Comparison of •NO bioavailability and physiological and cognitive 
function between dietary nitrate and placebo conditions 
Differences between placebo and nitrate conditions in variables that 
reflect •NO bioavailability and cognitive and physiological function 
were assessed using paired-samples t-tests (Table S2). Plasma concen-
trations of •NO biomarkers, nitrate and nitrite, were elevated and sys-
tolic blood pressure (SBP) was reduced after nitrate supplementation 
(Fig. 2 D, E). The plasma [nitrite]/[nitrate] ratio was lower in nitrate 
compared to placebo condition, which may reflect decreased efficiency 
of nitrate reduction, nitrate-reductase saturation, and/or alterations in 
nitrite oxidation and reduction pathways present in other tissues that 
contribute to plasma nitrate and nitrite concentrations (Fig. 2 F). The O2 
cost of sub-maximal treadmill walking was lower after nitrate supple-
mentation than placebo, indicating enhanced exercise efficiency (i.e., 
lower O2 cost for a given external work rate). There was no difference 
between conditions in maximal rate of skeletal muscle mitochondrial 
ATP resynthesis (Q̇max) which was estimated in the quadriceps muscles 
using quantitative 31Phosphorous magnetic resonance spectroscopy 
(31P-MRS). Physical functional capacity, assessed via a sit-to-stand test 
and a 6-min walk test (6MWT), was not altered by the interventions 
(Table S2). Cognitive performance in Rapid Visual Information 
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Processing (RVP) test, a measure of sustained attention, was enhanced 
following nitrate supplementation compared to placebo (Fig. 2 I). There 
were no differences in cognitive performance tests of short-term mem-
ory (number recall and serial subtractions), selective attention (Stroop 
test) and information processing speed (choice-reaction time). 1H-MRS 
brain scans revealed no differences between dietary conditions in N- 
acetyl aspartate (NAA), choline (Ch), creatine (Cr) or myo-inositol (mI) 
in occipito-parietal grey matter or in left frontal white matter (Table S2). 
Fig. 1. Flowchart illustrating the trial stages from participant enrolment to data analysis. PL, placebo; BR, nitrate.  
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2.3. Weighted oral microbiome co-occurrence network analysis and its 
relationship with cardiovascular and cognitive traits 
To identify biologically relevant correlations between the oral 
microbiome and indices of cardiovascular and cognitive health that 
were stable across placebo and nitrate conditions, we adapted WGCNA 
to create a weighted microbiome co-occurrence network [35]. Using a 
signed network where modules represented positively correlated OTUs 
and a soft thresholding value of >0.8, a total of eight distinct 
microbiome modules (MM1-MM8) were identified and 26 OTUs were 
unassigned to any module (Fig. S1). The size of the modules ranged from 
24 to 243 taxonomic units, and six of the modules included OTUs that 
were sensitive to dietary nitrate (Table 2). Most of the OTUs that 
increased with nitrate supplementation clustered together in MM5, with 
the exception of Rothia mucilaginosa (MM6) and Phycisphaera mikurensis 
(MM1), and two OTUs that were unassigned to a network (i.e., did not 
form significant correlations with neighbouring OTUs; Table 2). In 
contrast, most OTUs that decreased after nitrate supplementation clus-
tered together in MM2, with the few other declining OTUs scattered in 
MM1, MM3 and MM4. 
To identify module-driver OTUs that showed the highest connec-
tivity to other OTUs within a given module we used linear discriminant 
analysis (LDA) effect size (LEfSe), a method that has been validated for 
biomarker identification within the human microbiome [43]. The 
module-driver OTUs for each module exceeding a logarithmic LDA score 
threshold of 2 are illustrated in Fig. 3. We found that eight 
module-driver OTUs were nitrate-sensitive, including two OTUs that 
increased (MM5: Neisseria lactamica; MM6: R. mucilaginosa) and six 
OTUs that decreased (MM1: Spirochaeta africana; MM2: Clostridium 
difficile, Megasphaera elsdenii, Prevotella intermedia, Ruminococcus tor-
ques; MM4: Roseburia hominis) with dietary nitrate supplementation. 
To screen for functional significance of the microbiome modules, we 
Table 1 
Participant characteristics, relative daily NO3− dose and salivary flow rate 
questionnaire (SFR-Q) results (n = 30; men = 13, female = 17).   
Range (mean ± SD) 
Age, y 70 - 80 (73 ± 3) 
Height, cm 152 - 191 (167 ± 11) 
Body mass, kg 51.4 – 103.0 (70.5 ± 13.6) 
BMI, kg/m2 19.7- 33.1 (25.0 ± 3.3) 
ACE-III, total score (/100) 82 - 99 (92 ± 5) 
SFR-Q mean score 1.0 - 2.7 (1.6 ± 0.5) 
NO3− dose (mmol/kgBM/d) 0.12 – 0.24 (0.18 ± 0.03) 
BMI, body mass index; ACE-III, Addenbrooke’s Cognitive Examination Ques-
tionnaire, score out of 100 presented; BMI, body mass index. 
Fig. 2. The Shannon diversity index (A) and Chao 1 (B) indicated no differences in species diversity between placebo (PL) and nitrate (BR) conditions. Non-metric 
multidimensional scaling (NMDS) revealed that the overall salivary microbiome composition differed between PL and BR (C). Significant differences in physiological 
and cognitive traits between PL and BR included increases in plasma nitrate ([NO3− ]) and nitrite ([NO2− ]) concentration (D, E); decrease in plasma [NO2− ]/[NO3− ] ratio 
(F); and decreases in systolic blood pressure (SBP) (G), pulmonary O2 uptake relative to walking speed (H), and number of errors in the RVP test of sustained 
attention (I). In panels D-I blue symbols and lines indicate mean ± SD and red dashed lines show individual responses. (For interpretation of the references to colour 
in this figure legend, the reader is referred to the Web version of this article.) 
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summarised each module according to an intramodular hub gene 
(‘eigengene’, i.e., the first principal component of module microbiome 
expression) and created eigengene correlation networks with physio-
logical and cognitive traits. The ACE-III characterisation was performed 
at baseline only, since it was not expected that cognitive status would 
change during a 10-day dietary intervention. ACE-III cognitive traits 
were therefore analysed as part of the PL condition eigengene network. 
MM6 positively correlated with ACE-III total (r = 0.45, P = 0.01), 
fluency (r = 0.42, P = 0.03) and language scores (r = 0.41, P = 0.03), 
MM4 positively correlated with ACE-III language score (r = 0.51, P =
0.007) and MM1 inversely correlated with ACE-III memory score (r =
− 0.40, P = 0.04) (Fig. 4A). ACE-III total score correlated with physical 
functional capacity (6MWT, r = 0.49, P = 0.017), MAP (r = − 0.47, P =
0.0090), BMI (r = − 0.46, P = 0.011), memory and concentration (serial 
subtractions, r = 0.46, P = 0.011), and brain white matter Ch (r = 0.42, 
P = 0.035). Compared with the participants with an ACE-III total score 
of >90 (n = 21), participants with mild cognitive impairment (n = 9) 
had a higher body mass index (BMI) (27 ± 3 vs 24 ± 3 kg/m2) and SBP 
(137 ± 10 vs 126 ± 15 mmHg), and lower brain white matter Ch:Water 
ratio (0.62 ± 0.21 vs 0.92 ± 0.34) (all P < 0.05). 
Next, we surveyed 520 module-trait eigengene correlations (8 
modules x 32 traits x 2 dietary conditions) and found 19 significant 
relationships within the placebo and 19 within the nitrate condition 
(Fig. S2 AB). However, most of these significant correlations were not 
stable across both dietary conditions, suggesting that they may be 
spurious rather than causal. To assess the stability of the microbiome 
module-trait correlations across dietary conditions we further reduced 
the data to a consensus network [35] and found that only three signif-
icant correlations remained: MM5 correlated with reaction time in the 
‘information processing’ cognitive function test (r = − 0.39, P = 0.05), 
MM6 correlated with MAP, (r = − 0.44, P = 0.03), and MM7 correlated 
with V̇O2 at rest (r = 0.48, P = 0.01) (Fig. 4B). Plasma •NO biomarkers, 
muscle bioenergetic indices, and brain metabolites showed several sig-
nificant correlations with microbiome modules in either the placebo or 
nitrate condition (Fig. S2), but none of these evidenced stability in the 
consensus network (Fig. 4B). 
3. Discussion 
Microbiome-diet interactions are emerging as a therapeutic target for 
the maintenance of cardiovascular and cognitive health in older age [44, 
45]. While there is robust evidence to suggest that the oral microbiota as 
a whole plays a key role in the maintenance of systemic •NO homeo-
stasis, attempts to link individual bacterial species to •NO-mediated 
functional outcomes miss the context of complex synergistic and 
antagonistic interactions within the oral bacterial community. There-
fore, causal inferences drawn from cross-sectional comparisons have 
limited translational potential for advancing healthy ageing in humans. 
We applied a systems biology approach to detect biologically- 
relevant features of the nitrate-sensitive oral microbiome in 70–80 
year-old men and women. Our network-driven analysis systematically 
reduced the bacterial 16S rRNA sequencing data to reveal two modules 
of co-occurring bacteria (MM5 and MM6) that exhibited both 1) nitrate- 
sensitivity and 2) stable correlations with blood pressure (MM6) or 
cognitive function (MM5) across two distinct dietary conditions. In 
addition, we identified another microbiome module (MM7) that was not 
nitrate-sensitive, but showed a stable correlation to O2 uptake at rest. 
There is a remarkable consistency in the clustering of oral microbiota 
irrespective of age and ethnicity of the subject population as well as the 
sequencing and bioinformatics approaches taken to analyse microbiome 
data (46, 47, 48; present study). The number of oral microbiome mod-
ules identified has varied across studies (~2–8), but the most consis-
tently identified modules include the Prevotella-Veillonella (MM2; 46, 47, 
48), Neisseria-Haemophilus (MM5; 47, 48), and Streptococcus-Rothia 
clusters (MM6; 47, 48). We showed that it was possible to manipulate 
the relative proportions of these ‘universal’ oral microbiome clusters via 
a simple, short-term dietary nitrate supplementation in a population of 
70–80 year-old individuals who followed their habitual omnivorous diet 
throughout the study; specifically, the Prevotella-Veillonella cluster was 
diminished, while the Neisseria-Haemophilus and Streptococcus-Rothia 
clusters thrived under nitrate supplementation. In terms of oral health, 
the Prevotella-Veillonella module has been associated with proteolytic 
metabolism and an early inflammatory state with a dysbiotic prognosis 
[48]. This module is also predominant in smokers [49], and positively 
associated with periodontitis [50] and pneumonia in older people [47]. 
Table 2 
The distribution of nitrate-sensitive bacteria among microbiome modules 1–8 
(MM1-MM8) and module-driver species exceeding LDA score threshold of 2. 
Bold font indicates nitrate-sensitive module drivers. * No taxonomic unit 
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In contrast, a Neisseria-Haemophilus dominated oral microbiome has 
been associated with periodontal health, younger age, lower BMI, and 
abstinence from smoking [49]. Neisseria, Haemophilus and Rothia are 
among bacteria that dominate the oral microbiomes of vegans, while the 
omnivorous diet favours Prevotella and Streptococcus [46]. Our findings 
from a placebo-controlled, cross-over dietary intervention with 
nitrate-rich and nitrate-depleted beetroot juice indicate that the greater 
Neisseria/Prevotella ratio reported in vegans compared to omnivores 
[46] was likely due to differences in dietary nitrate intake. Collectively, 
this ecosystemic shift following dietary nitrate supplementation away 
from Prevotella-Veillonella and towards dominance by Neisser-
ia-Haemophilus and Streptococcus-Rothia modules, may have positive 
implications for oral and systemic health. 
Alongside the shift in the oral microbiome, the dietary nitrate 
intervention resulted in beneficial changes in systemic •NO bioavail-
ability, blood pressure, O2 cost of walking, and sustained attention that 
were indicative of improved cardiovascular, metabolic and cognitive 
function. A key strength of the current study design was the ‘interven-
tionist’ approach [34] that enabled us to test the stability of correlations 
between co-occurring oral microbiome modules and physiological and 
cognitive traits across two distinct dietary conditions using a consensus 
network [35]. We found that the inverse correlation between MM6 
(Streptococcus-Rothia module) and MAP, was sufficiently stable to persist 
when subjected to the consensus network. This module was mainly 
made up of Firmicutes and Actinobacteria, including 24 Streptococcus 
species (e.g. S. mitis, S. parasanguinis and S. salivarius) and two Rothia 
species (R. dentocariosa and R. mucilaginosa), but among the module 
drivers within MM6, only R. mucilaginosa was sensitive to nitrate sup-
plementation (Table 2). The presence of streptococci, a core component 
in a healthy oral ecosystem, correlates positively with markers of 
vascular health (high-density lipoprotein and apolipoprotein AI; 51) and 
R. mucilaginosa is a potent nitrate-reducer [8], that positively correlates 
with systemic •NO biomarkers [27]. The sensitivity of MM6 to dietary 
nitrate is of considerable therapeutic significance, given that elevated 
blood pressure represents a primary risk factor for cardiovascular dis-
eases, the leading cause of mortality in the developed world [52]. A diet 
rich in inorganic nitrate throughout the lifespan and particularly in older 
age, may have a beneficial influence on the oral microbiota with asso-
ciated reduction in the risk for developing cardiovascular diseases. 
There was a positive consensus correlation between O2 uptake at rest 
and MM7, a relatively small bacterial module that was not nitrate- 
sensitive and had no species-level module drivers exceeding the LDA 
score threshold. The metabolic underpinnings of this stable correlation 
across the two dietary conditions are unclear. The O2 uptake at rest, 
measured with the participant standing astride the treadmill prior to the 
commencement of exercise test, reflects the body’s metabolic rate, 
which is influenced by lean tissue mass, metabolic properties of tissue, 
and environmental conditions. Although nitrate supplementation 
Fig. 3. Linear discriminant analysis (LDA) effect size (LEfSe) was used to identify operational taxonomic units (OTU) driving the differences between placebo (PL) 
and nitrate (BR) conditions within oral microbiome modules 1–6 (MM1-MM6). Within MM3, MM7 and MM8 no OTU exceeded the logarithmic LDA score threshold 
of 2. 
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resulted in a considerable increase in plasma •NO biomarkers, there 
were no significant consensus-level correlations between nitrate or ni-
trite concentration and any microbiome module. This result may reflect 
the fact that •NO is omnipresent in the human body and is not produced 
solely through the nitrate-nitrite-NO pathway involving the oral 
microbiota, but also via the NOS-enzyme pathway and the nitrate- 
reductase activity of the gut microbiota [53]. It should also be noted 
that total bacterial mass and metabolic activity, which are not quantified 
by 16S sequencing, also influence the volume of oral nitrite production 
and should be considered alongside relative abundances of bacteria. 
The first signs of cognitive decline predominantly manifest as deficits 
in executive function, sustained attention, and information processing 
speed [54]. Our findings that a short-term dietary nitrate intervention 
improved sustained attention (reduced number of errors in the RVP 
test), and that information processing speed (in Decision-Reaction test) 
was inversely correlated with the nitrate-sensitive Neisseria-Haemophilus 
Fig. 4. A: Eigengene correlation network between the Addenbrooke’s Cognitive Examination (ACE-III) cognitive traits at baseline and microbiome modules (MM1- 
MM8) within the PL condition. B: Consensus correlation network between oral microbiome modules and 32 cognitive and physiological traits. Only three significant 
consensus module-trait relationships persisted across placebo and nitrate conditions: MM5 correlated with reaction time in the ‘information processing’ cognitive 
function test, MM6 correlated with MAP, and MM7 correlated with pulmonary O2 uptake at rest. The colour scale on the right-hand side of each panel indicates the 
strength of positive (green) and inverse (red) correlations. (For interpretation of the references to colour in this figure legend, the reader is referred to the Web version 
of this article.) 
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module (MM5), therefore have potential for the development of in-
terventions to delay the progression of cognitive decline. It was also 
noteworthy, that the baseline cognitive status assessed through ACE-III 
questionnaire correlated with the Streptococcus-Rothia module (MM6), 
and that P. intermedia, a module driver (MM2) that has been implicated 
as a predictor of cognitive decline [55], decreased significantly after 
nitrate supplementation. The known periodontal pathogens Porphyr-
omonas gingivalis, Treponema denticola and Tannerella forsythia that have 
emerged as correlates of cognitive decline and Alzheimer’s disease [56] 
clustered together in MM4, which diminished after nitrate supplemen-
tation. Low relative abundances of these pathogens (~0.02–0.06%) are 
representative of the comparatively good health status of the study 
cohort. Further randomised controlled trials are warranted to test the 
robustness of the cognitive state versus Streptococcus-Rothia module 
relationship in an interventionist consensus network, and to explore the 
use of dietary nitrate as a preventative long-term intervention for 
attenuating progression of cognitive decline. 
Elevated blood pressure is a risk factor for cognitive decline in 
middle-aged and older populations up to approximately 84 years of age 
[57]. Accordingly, both MAP and cognitive status at baseline correlated 
with the Streptococcus-Rothia module. A common denominator in 
cognitive and cardiovascular decline in older age is a chronic low-level 
inflammation [58]. Oral bacteria might underpin inflammation by 
affecting host metabolism (including •NO homeostasis) while residing in 
the oral cavity and/or via bacterial migration beyond their native 
habitat, e.g., to the vascular endothelium forming atherosclerotic pla-
ques [51]. Atherosclerosis risk is linked to the oral microbiome [59], and 
a meta-analysis of 63 studies and 1791 patients identified P. intermedia 
among five oral bacteria found uniquely in coronary atherosclerotic 
plaque [60]. Decreased •NO bioavailability encourages leukocyte 
recruitment and systemic inflammation, and indeed, dietary nitrate 
supplementation that elevates •NO bioavailability has been shown to 
attenuate inflammation and result in a more stable plaque phenotype in 
a mouse model of atherosclerosis [61]. It is also interesting to note that 
the dietary nitrate supplementation decreased four microbiome module 
drivers including P. Intermedia and Clostridium difficile in MM2, which 
has been characterized by proteolytic and pro-inflammatory metabolism 
[48] and which contains bacteria that might stimulate atherosclerotic 
processes in the vasculature when the oral-blood barrier is breached. 
The novel observation that dietary nitrate supplementation decreased 
the relative abundance of oral C. difficile, possibly arising from cidal 
activity of reactive oxides produced from acidified nitrite [62], may 
have implications, for example, for infection prevention during proton 
pump inhibitor treatment in clinical practice and in long-term-care fa-
cilities [63]. 
Sequencing of the ribosomal 16S genes provides a cost-effective 
characterisation of the microbiome and enables useful comparisons to 
be made between populations or conditions. However, 16S sequencing 
has modest accuracy in identification of species level OTUs, and unlike 
whole genome sequencing (WGS), it does not enable verification of 
nitrate-reductase genes in given OTUs. Therefore, while our results 
provide an instructive overview of the nitrate-sensitive host-oral 
microbiome network, further research is required to confirm specific 
species-level biomarkers for targeted probiotics development. It should 
be noted when drawing comparisons between studies, that the quanti-
ties as well as relative abundances of bacteria vary between different 
oral sites, with nitrate-reducing bacteria being most abundant on the 
dorsum of the tongue [8]. We chose saliva sampling because it provides 
an overall characterisation of the microbial communities present across 
all oral sites, and the relative abundances of dominant bacteria in saliva 
are closely correlated to those on the tongue dorsum [64]. The supple-
mentation period of 10 days is deemed sufficiently long to yield signif-
icant changes in key variables measured in the present study, where we 
aimed to characterise a broad range of physiological and cognitive re-
sponses to nitrate supplementation that may correlate with the oral 
microbiome. While we excluded participants with known periodontal 
diseases, the oral health status of participants was self-reported and not 
based on oral examination. Future research is warranted to explore the 
influence of various lifestyle factors (e.g., diet, oral hygiene routines) on 
the efficacy of prebiotic nitrate supplementation, as well as the effects of 
longer supplementation periods on cognitive status using bespoke 
cognitive test batteries. 
The principal novel contribution of this study was the identification 
of co-occurring modules of bacteria (MM5 and MM6), which exhibited 
consistent correlations to indices of human health across dietary in-
terventions. Characterisation of the in vivo oral ecosystem in this way is a 
major advance to using isolated OTUs [27,29] or arbitrarily grouped 
OTUs [30,31] for correlational analyses with physiological variables. 
Importantly, we also showed that nitrate supplementation diminished 
MM2, which has been associated with inflammatory metabolism [48] 
and contained oral pathogens such as C. difficile. The network approach 
originally developed for human genome research applied in a novel 
context of the oral microbiome to account for complex interactions 
among oral bacteria, enabled us to identify Neisseria (MM5) and Rothia 
(MM6) OTUs, which: 1) both increased significantly with nitrate sup-
plementation, 2) represented module-drivers with the most connectivity 
to their neighbouring OTUs, and 3) presented stable correlations with 
cardiovascular or cognitive function. While these OTUs may be 
considered to have promise as new probiotics, it is important to note that 
a single-taxon focus can be misleading because the gene expression and 
signalling cascades of a given bacterial species are modulated by its 
co-inhabitants in the collective microbial ecosystem [65]. Therefore, for 
optimal ecosystem-wide effects, potential probiotics should be com-
bined with dietary nitrate supplementation as a prebiotic ancillary, as 
well as other bacterial species identified as module drivers (irrespective 
of nitrate-reductase activity) within the desired microbiome module. 
4. Materials and methods 
4.1. Participants 
This trial (NCT03473678) was approved by the institutional 
Research Ethics Committee (Sport and Health Sciences, University of 
Exeter) and conformed to the World Medical Association (WMA) 
Declaration of Helsinki. Participants gave their informed, written con-
sent after the experimental procedures had been discussed, and potential 
risks and benefits of participation had been explained. Exclusion criteria 
included known illnesses, including oral diseases, the wearing of den-
tures, and tobacco and prescription medication use. Participants were 
instructed to arrive at the laboratory in a rested and fully hydrated state, 
at least 3 h postprandial, and to avoid strenuous exercise in the 24 h 
preceding each laboratory visit. Participants were asked to follow their 
habitual diet and physical activity pattern and refrain from using 
mouthwash throughout the study. Participants were also advised to 
avoid caffeine and alcohol intake 6 and 24 h before each visit. All tests 
were performed at approximately the same time of day (±2 h) for each 
subject. Participants completed the Addenbrooke’s Cognitive Examina-
tion III [40] and salivary flow rate [66] questionnaires at baseline 
(Table 1) and were familiarised with test protocols for physiological and 
cognitive traits. 
4.2. Dietary interventions 
Participants were assigned in a double-blind, randomised, crossover 
design to receive 10 days of dietary supplementation with concentrated 
NO3− -rich BR (2 × 70 ml d− 1, organic beetroot juice each containing 
~595 mg NO3− , Beet it, James White Drinks, Ipswich, UK) and NO3−
-depleted PL (2 × 70 ml d− 1, organic beetroot juice containing ~1 mg 
NO3− , Beet it, James White Drinks, Ipswich, UK). The PL beverage was 
created by passage of the juice, before pasteurisation, through a column 
containing Purolite A520E ion exchange resin, which selectively 
removes NO3− ions [67]. The PL product was identical to the BR in 
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appearance, taste and smell. Participants were instructed to consume 
one of the 70 ml beverages in the morning and the other in the afternoon 
each day, and on laboratory visit days, to consume their final beverage 
2.5 h prior to the laboratory visit. A wash-out period of at least 72 h 
separated each supplementation period and participants were instructed 
to maintain their habitual daily activities and food intake throughout 
the study. Participants attended the laboratory on days 8, 9 and 10 of 
each supplementation period for the assessment of physiological and 
cognitive traits. Upon arrival at the laboratory on each of these visits, 
venous blood samples were drawn, resting BP was measured, and a 
saliva sample collected (by expectoration, without stimulation) for the 
assessment of the salivary microbiome. Plasma [NO3− ] and [NO2− ] were 
assessed using ozone-based chemiluminescence [68] and the mean 
values of three measurements was calculated. The three saliva samples 
for each individual were pooled for analysis of the salivary microbiome. 
4.3. Physiological traits 
Venous blood samples were drawn from the antecubital vein and 
seated blood pressure was measured in accordance with European So-
ciety of Hypertension guidelines ([69]; Dinamap PRO 100V2, GE Med-
ical Systems Information Technology, Tampa, USA). During a baseline 
visit, participants completed an incremental exercise test on a treadmill 
(Woodway ELG 55, Woodway Gmbh, Weil am Rhein, Germany) for the 
assessment of the gas exchange threshold (GET; 17). During experi-
mental visits, participants were asked to complete a ‘Sit to Stand 10 Test’ 
(stand from a standard chair 10 times as quickly as possible), and a 
walking exercise test on a treadmill for the determination of pulmonary 
oxygen uptake (V̇O2; Oxycon Pro, Jaeger, Hoechburg, Germany). The 
protocol involved three 6-min bouts of low-intensity walking at a speed 
equivalent to 90% of the GET [17]. Each exercise bout involved an 
abrupt transition to the target speed initiated from a slow walking 
baseline (1 km h− 1), with the three exercise bouts separated by 10 min of 
passive recovery. Following a 15 min passive recovery period, the par-
ticipants completed a 6-Min Walk Test (6MWT) on a straight, flat track 
to assess functional capacity in accordance with the American Thoracic 
Society guidelines [70]. 
4.4. Cognitive traits 
Participants were asked to complete five computer-based cognitive 
function tests which assessed the speed and accuracy of response during 
cognitively demanding tasks. Participants completed: 1) the Rapid Visual 
Information Processing test (RVP), to assess sustained attention; 2) the 
Number Recall test, to assess short-term working memory; 3) the Stroop 
test to assess information processing speed, executive abilities and se-
lective attention; 4) the Decision-Reaction test, to assess information 
processing speed; and 5) the Serial Subtractions test by serial threes and 
serial sevens, to assess concentration and memory. 
4.5. 31P-MRS of the quadriceps muscle and 1H-MRS of the brain 
Participants were asked to complete single-leg, knee-extension ex-
ercise tests while lying prone in the bore of a 1.5 T superconducting MR 
scanner (Gyroscan Clinical Intera, Philips, The Netherlands). First, 
muscle phosphocreatine ([PCr]), inorganic phosphate ([Pi]), adenosine 
triphosphate ([ATP]) and [pH] dynamics were assessed during two low- 
intensity knee-extension exercise bouts (each 4 min). Then, participants 
were asked to complete two 24-s high-intensity knee-extension exercise 
bouts, separated by 3 min 36 s rest, to assess muscle phosphocreatine 
(PCr) recovery kinetics, which represents the maximal rate of mito-
chondrial ATP resynthesis, and thus an index of muscle oxidative ca-
pacity (Q̇max; [71]). During the same visit to the MR scanner, brain 
metabolites including N-acetyl aspartate (NAA), creatine (Cr), choline 
(Ch), myo-Inositol (mI) of left frontal white matter and occipito-parietal 
grey matter were measured using 1H MRS following the methods by 
Kelly et al. [17]. 
4.6. DNA extraction and 16S illumina sequencing 
Genomic DNA (gDNA) from the saliva samples was extracted using 
the method by Goode et al. [41]. Briefly, DNA stabilisation buffer and 
cell lysis solution was added to the saliva samples, mixed, and incubated 
at room temperature for 30 min. RNAse solution was added to the 
samples and these were incubated on ice for the removal of RNA. Pro-
teinase K solution and protein precipitation solution were then added to 
remove proteins and lipids. For isolation of gDNA, glycogen solution and 
isopropanol were added and centrifuged for 30 min at 3000 g and 4 ◦C. 
The gDNA was purified using an ethanol wash and rehydrated with 
Tris-EDTA. DNA concentration was quantified using Qubit 
high-sensitivity fluorescence detection (Qubit 3.0, ThermoFisher Sci-
entific, Waltham, MA). Library preparation employed a NEXTflex 16S 
V1 – V3 Amplicon-Seq Kit (Bioo Scientific, Austin, TX). 16s V1–V3 rDNA 
was selectively amplified using universal primers. Following AMPure® 
XP bead cleanup (Becton Dickinson, Franklin Lakes, NJ), a subsequent 
PCR with indexing primers to identify individual samples, containing 
Illumina flow cell binding sites, was performed. Paired-end 300 meta-
genomic next generation sequence analysis was performed on the MiSeq 
Illumina platform (Illumina, San Diego, CA) using v3 MiSeq reagents. 
Nucleotide sequence data in FASTQ format was trimmed and processed 
by the Kraken 2 Taxonomic Sequence Classification System [72]. Vari-
ations in the V1–V3 regions enabled taxonomic identification. 
4.7. Weighted microbiome co-occurrence network analysis 
WGCNA was adapted to group highly correlated OTUs and correlate 
the groups with physiological traits (WGCNA R version 6.3). Data were 
filtered by removing counts of less than five in >50% of the samples and 
transformed in accordance with methods described by Langfelder & 
Horvath [35]. An analysis of the network topology was performed using 
a signed consensus network for PL and BR where the soft thresholding 
value was at least 0.8 in PL and BR. In module identification, spurious 
associations were minimised by transforming the adjacency matrix to a 
topological overlap matrix. A hierarchical clustering tree was used for 
OTU clustering and module identification (Fig. S2). Module eigengenes 
for PL and BR were correlated with the physiological traits. A consensus 
network was used to determine the concordance and differences be-
tween the networks [35]. Linear discriminant analysis (LDA) of effect 
size (LefSE) was used to identify key biomarkers within in each module 
and compare the statistically different features in PL and BR. The 
‘all-against-all’ strategy for multiclass analysis was used with a loga-
rithmic LDA score threshold of 2 [43]. 
4.8. Statistical analyses 
Differences between placebo and nitrate conditions in •NO 
bioavailability, and physiological and cognitive traits were assess using 
paired-samples t-tests. Non-metric multidimensional scaling (NMDS) 
was used to assess the level of similarity in microbiomes between con-
ditions using non-parametric relationships and were analysed using 
ADONIS (Vegan R Software). Differences between conditions in bacteria 
that made up >0.01% of total bacteria were assessed using Benjamini- 
Hochberg-adjusted paired t-tests (R statistical software; 42). The 
Shannon-Wiener diversity index (H’) was used to explore differences in 
diversity (Vegan R Software). Statistical significance was defined as P ≤
0.05. 
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